NCT04732416 · Interventional trial
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
Overall registry status Active not recruiting
Phase 2
Conditions Congenital Hyperinsulinism
Delaware Valley sites
- The Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory